Humasis ranked among the top searched stocks on 11 days in the past month.

As of 11:31 AM on the 18th, Humasis is trading at 14,050 KRW, up 5.64% from the previous day. This is a 18.31% decrease compared to August 6. Humasis is known as an in vitro diagnostic device company.

Over the past five days, individual investors have sold a net 160,428 shares, while foreigners and institutions have bought a net 277,364 shares and 3,047 shares, respectively.

On August 12, Humasis became a market issue with the news of "COVID-19 diagnostic kit sales in the U.S. up 8.45%".

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing